Plain-English translation of NCT06068257 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Colorectal Cancer research guide โResearchers are studying whether a protein called FGF19 found in blood can be used as a simple test to detect colorectal cancer and breast cancer. This research aims to develop a blood-based screening tool that could catch cancer earlier and be easier and more convenient than current screening methods like colonoscopies and mammograms.
Many people avoid standard cancer screening tests because they are uncomfortable or inconvenient, which means cancers are often found at later stages when they are harder to treat. This study exists to create an easier alternative โ a simple blood test โ that could help more people get screened and catch cancer earlier, ultimately saving lives.
If you qualify, you will visit the study site for a fasting blood draw โ meaning you will not eat or drink beforehand. The researchers will collect a blood sample and test it for the FGF19 protein to see if it can reliably detect cancer. The study compares results from people with colorectal cancer, people with breast cancer, and healthy people without cancer to understand how well this blood test works.
AI-generated summary from trial data ยท Jul 18, 2026 ยท Not medical advice
United States
Enrollment target
~119 participants
Started
June 2023
Primary completion
June 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in July 2026.